Access to rehabilitation or other therapies for symptom management Rehabilitation or therapy available in country of interest? World Bank category Lower middle income WHO region European Global results
% of countries reporting people can access rehabilitation or other therapies for each symptom
Fatigue Yes 52% 75% 59.00%
Heat sensitivity No 9% 35% 25.00%
Difficulty walking Yes 91% 95% 93.00%
Stiffness and spasms Yes 91% 95% 91.00%
Bladder problems Yes 61% 85% 73.00%
Memory and other cognitive problems No 39% 68% 57.00%
Pain and other unpleasant sensations No 70% 90% 77.00%
Emotional and mood problems No 70% 75% 69.00%
Vision problems No 43% 58% 52.00%
Dizziness or vertigo No 57% 73% 63.00%
Bowel problems No 43% 58% 56.00%
Tremors No 39% 73% 55.00%
Sexual problems No 35% 63% 51.00%
Difficulty moving arms/hands No 65% 85% 80.00%
Swallowing problems No 48% 78% 71.00%
Speech problems No 52% 75% 74.00%
Seizures No 65% 63% 60.00%
Not sure No 0% 0% 4.00%

What is the Atlas of MS?

The Atlas of MS is the most comprehensive worldwide study of the epidemiology of MS and the global availability and accessibility of resources for people with MS.

2020-22 worldwide study

The data shows that the number of people with MS across the globe has increased from 2.3 million in 2013 to 2.8 million in 2020 and 2.9 in 2023. It highlights the many barriers and inequalities that people with MS face in accessing diagnosis, treatment and care. Download the reports to see the full findings and recommendations or download the full dataset if you would like to conduct your own analysis comparing multiple countries.

Powerful tool for change

The information in the Atlas of MS can be a powerful advocacy tool, shining a spotlight on MS and raising awareness of the lack of adequate resources available to diagnose, inform, treat, rehabilitate and support people with MS worldwide.

With thanks to…

Worldwide collaboration

The Atlas of MS relies on data supplied by MS organisations from around the world. We are most grateful to the country coordinators and their colleagues for taking the time and effort to gather the information and data.

See contributor list

This 3rd edition of the Atlas of MS shines a spotlight on the barriers to accessing diagnosis and disease modifying therapies around the world. These issues are particularly evident in low and middle income countries but high income countries are not exempt. This report highlights the need for major policy changes to ensure early diagnosis and improved access to a range of treatments, to guarantee the best possible outcomes for people with MS. Information from the Atlas of MS should be used to guide policy-makers, health planners and specialists, in order to close the gaps in care, decrease inequities globally and provide a better future for people with MS and their families.

Professor Mai Sharawy
Professor of Neuro-Ophthalmology at Cairo University – Egypt.
Founder of MS Care and Chair of MSIF Board